Agios Pharmaceuticals, Inc. (AGIO) vs Vericel Corporation (VCEL)
Agios Pharmaceuticals, Inc. and Vericel Corporation are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Vericel Corporation are of similar size ($2.0B and $2.0B). Agios Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 82.6×. Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 140.6% against 23.0%. Vericel Corporation has the higher net margin (7.91% vs −418.2%) and the higher return on invested capital (5.49% vs −70.2%). Across the 18 metrics below, Vericel Corporation leads on 14 and Agios Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | AGIO | VCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | 74.56% | 65.16% |
| Operating margin | (466.78%) | 5.95% | 0.00% |
| Net margin | (418.24%) | 7.91% | 0.00% |
| Free cash flow margin | (371.43%) | 20.13% | 0.00% |
| Return on equity | (34.34%) | 7.16% | (57.72%) |
| Return on assets | (31.89%) | 5.16% | (49.22%) |
| Return on invested capital | (70.24%) | 5.49% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack